The Latest Breaking News from Pfizer

State attorney general Ken Paxton files suit despite medical consensus that vaccine prevents severe infection and death

The Innovator IBD 50 ETF outperformed with a 0.6% gain and could make its first close above the 200-day moving average since Sept. 12.

Pfizer will retool its obesity drug efforts, but the delay is a blow to the group's ambitions to challenge Novo Nordisk and Lilly in the fast-developing space.

Experts argue other assertions made in the lawsuit filing are completely unsubstantiated, such as one claiming that vaccinated people were more likely to die from COVID-19, which Texas health data disputes.

Unlike many of its peers, GSK just reported a big year-over-year jump in vaccine sales - and there's more growth to come, as the pharmaceutical company expands both its pipeline and the geographical reach for its vaccines.

It's only November — but if you're like most investors — 2024 is what matters now. And some S&P 500 companies already look primed to put up big numbers.

The team discovered that people who previously received AstraZeneca or Sinopharm COVID-19 vaccines had a "non-inferior" immune response when given a half dose of a Pfizer COVID-19 booster vaccine, comparable to those who received a full dose.

Social media users shared a range of false claims this week

As the COVID virus continues to evolve, so does our vaccine response. From December 11, Australians will have access to new vaccines that offer better protection.

Rodgers isn't coming back from that one.

Most meds have side effects, some subtle, some difficult to handle. However, some drugs have positive side effects, like finasteride for hair growth and sildenafil for impotence. Side effects can be monitored and, with shrewdness, can be used to benefit mankind. Be on the lookout for positive effects when taking…